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ABSTRACT 
 
Porterfield S, Linderman J, Laubach L, Daprano C. Comparison of 
the Effect of Caffeine Ingestion on Time to Exhaustion between 
Endurance Trained and Untrained Men. JEPonline 2013;16(5):90-98. 
This study compared the ergogenic effects of caffeine on men who 
were endurance trained to those who were untrained. The study was 
a double-blind, placebo-controlled crossover experimental design. 
Ten endurance trained men (mean age 24.4 ± 2.0 yrs, weight 79.4 ± 
8.5 kg, predicted VO2 max 46.3 ± 1.8 mL·kg-1·min-1) and 10 untrained 
men (mean age 22.8 ± 1.9 yrs, weight 88.9 ± 9.9 kg, predicted VO2 
max 37.6 ± 2.7 mL·kg-1·min-1) completed two cycle ergometer trials to 
exhaustion at 80% of their predicted workload max 30 min after 
ingesting either 5 mg·kg-1 of body weight of caffeine or a placebo. 
Neither group displayed significant increases in time to exhaustion 
(Trained Group: 786.4 ± 251.5 sec for the placebo trial and 810.7 ± 
209.4 sec for the caffeine trial and the Untrained Group: 514.6 ± 107.8 
sec for the placebo trial and 567.3 ± 140.5 sec for the caffeine trial) 
after ingesting caffeine. When compared statistically between groups, 
the difference was not significant. When the groups were combined, 
the difference was caffeine and the placebo was not significant. The 
findings indicate that there was no ergogenic effect of caffeine on time 
to exhaustion in either endurance trained or untrained men. 
 
Key Words: Ergogenic Aid, Cycle Ergometry, YMCA Protocol, 
Predicted VO2 max, Predicted Workload Max 
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INTRODUCTION 
 
The use of ergogenic aids has become increasingly popular in the past several decades (3,10,17).  
One aid of particular interest to athletes is caffeine. It is most commonly seen in beverages such as 
cola, coffee, tea, and energy drinks. It is easily accessible to just about anyone, and is very widely 
accepted by most social groups (11). Caffeine works as an ergogenic aid by stimulating the release of 
catecholamines in the cardiovascular, muscular, and central nervous systems (13). It is also reported 
that caffeine stimulates the secretion of adrenaline and increases fat utilization during exercise (12).  
As a result, Jenkins et al. (11) concluded that since the 1970s caffeine has been considered as an 
ergogenic aid (especially during aerobic exercise to exhaustion). 
 
Because of its known ergogenic effect in high doses, caffeine has been banned by the National 
Collegiate Athletic Association (NCAA), United States Olympic Committee, and at one time the 
International Olympic Committee (IOC).  In order to produce a positive test, urine concentration levels 
must be ≥ 15 µg·mL-1 (12). While an average person is likely to require about 800 mg before 
competition or around 10 mg·kg-1 of body weight to produce a positive test, numerous research 
studies (2,8,9,14,19) indicate that the most effective dose as an ergogenic aid is ~5 mg·kg-1 of body 
weight (Table 1). However, it is important to point out that the ergogenic effects have been seen in as 
little as 1 to 2 mg·kg-1 of body weight (2,3,5,12).  
 
According to Desbrow and Leveritt (4), who administered a questionnaire to 140 (105 male and 35 
female) athletes at the 2005 Ironman Triathlon World Championships, 89% of the athletes planned to 
use caffeinated substance prior to or throughout the race. Athletes understand that essentially every 
person in endurance sports is likely to use caffeine to harness its ergogenic effects. While there are 
individual differences, in general, upon entering the body caffeine reduces the loss of glycogen during 
endurance sports by increasing the use of fat as the primary fuel source.  
 
Bell and McLellan (2) examined how caffeine versus a placebo affected the time to exhaustion in 9 
men while riding a cycle ergometer (Table 1). With the ingestion of 5 mg·kg-1 of body weight of 
caffeine, the subjects rode 38.3% longer (24.9 min vs. 18.0 min) than when they ingested a placebo 
and 23.2% longer (21.8 min vs. 17.7 min) when they ingested 2.5 mg·kg-1 of body weight of caffeine. 
Hoffman et al. (8) examined the effect of caffeinated versus decaffeinated coffee on cycle ergometer 
time to exhaustion. During the caffeine trials, the subjects ingested 450 mg of caffeine. The subjects’ 
time to exhaustion was significantly longer during the caffeinated coffee trial (35.3 min) than during 
the decaffeinated coffee trial (27.3 min). Hogervorst et al. (9) found similar results with a lower dose 
(100 mg) of caffeine (27.8 min vs. 21.9 min) (refer to Table 1). 
 
McLellan and Bell (14) examined whether the prior consumption of coffee (COF) would decrease the 
ergogenic effect of a subsequent ingestion of anhydrous caffeine (CAF). Thirteen subjects performed 
6 rides to exhaustion at 80% of VO2 max 1.5 hrs after ingesting combinations of COF, decaffeinated 
coffee (DECOF), CAF, or placebo. The conditions were: (a) DECOF + placebo; (b) DECOF + CAF (5 
mg·kg-1); (c) COF (1.1 mg·kg-1 caffeine) + CAF (5 mg·kg-1); (d) COF + CAF (3 mg·kg-1); (e) COF + 
CAF (7 mg·kg-1); and (f) and colored water + CAF (5 mg·kg-1). The subjects’ times to exhaustion were 
significantly greater for all trials with CAF versus the placebo (trial “a”). Exercise times (in minutes) 
were: 21.7 ± 8.1, 29.0 ± 7.4, 27.8 ± 10.8, 25.1 ± 7.9, 26.4 ± 8.0 and 26.8 ± 8.1 for trials “a” through “f” 
respectively. They concluded that the prior consumption of COF did not decrease the ergogenic effect 
of the subsequent ingestion of anhydrous CAF (i.e., the dry powder form of caffeine) (see Table 1). 
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Table 1. Brief Overview of the Current Literature. 
Reference Sample 
Size 
Age (yrs) Fitness Level 
(mL·kg-1·min-1) 
Dose Intensity 
(VO2 max) 
Time to  
Exhaustion (min) 
%Δ 
         
      CAF Placebo  
         
Bell & McLellan 9 33.0 ± 7.0 52.0 ± 9.0 2.5 mg·kg-1 80% 21.8 18.0 ↑23.2 
    5.0 mg·kg-1  24.9 17.7 ↑38.3 
         
Hoffman et al. 10 20.9 ± 1.7 51.9 ± 8.7 450 mg 75% 35.3 27.3 ↑29.3 
         
Hogervorst et al. 24 23.0 ± 5.0 56.6 ± 4.7 100 mg 75% 27.8 21.9 ↑27.0 
         
McLellan & Bell 13 34.0 ± 8.0 52.0 ±  4.0 (m) 4.1 mg·kg-1 80% 25.1 21.7 ↑15.7 
   40.0 ± 3.0 (f) 5.0 mg·kg-1  29.0  ↑33.6 
    6.1 mg·kg-1  27.8  ↑28.1 
    8.1 mg·kg-1  26.4  ↑21.7 
         
Wong et al. 9 25.4 ± 6.9 51.0 ± 8.2 5.0 mg·kg-1 70% 110.1 83.6 ↑31.7 
         
 
 
What is still unclear is the effect of caffeine on untrained subjects (i.e., individuals with predicted VO2 
max values in the bottom 40th percentile). Due to the lack of research with untrained subjects, given 
that all the subjects in Table 1 fall into the trained group, it is difficult to compare the effect of caffeine 
ingestion on aerobic exercise between trained and untrained individuals. If it should be determined 
that caffeine does in fact show more of an ergogenic effect in one group versus the other, then future 
research studies may show stronger results if only one group is studied. Thus, the purpose of this 
study was to determine if caffeine has more of an ergogenic effect on endurance trained subjects 
than non-endurance trained subjects. 
 
METHODS  
Subjects 
The participants consisted of 20 male subjects who were placed into one of two groups (10 in each 
group) based on their predicted VO2 max values. Males with predicted VO2 max values in the top 
40th percentile (≥44.2 mL·kg-1·min-1) were placed in the Trained Group while males with predicted 
VO2 max levels in the bottom 40th percentile (≤41.0 mL·kg-1·min-1) were placed in the Untrained 
Group. The percentiles were determined by following the American College of Sports Medicine’s 
guidelines for exercise testing and prescription. Refer to Table 2 for the subjects’ mean age, body 
weight, body mass index (BMI), and predicted VO2 max in the Trained Group and the Untrained 
Group. Prior to testing, the subjects were required to complete a health history questionnaire. None of 
the subjects took any medication or performance enhancing supplements that might influence the 
outcome of the tests. Prior to testing, each subject consented to participate in the study based on the 
University of Dayton’s Institutional Review Board policies. This study was approved by the University 
of Dayton Institutional Review Board (Table 2). 
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Table 2. The Trained and Untrained Subjects’ Descriptive Data. 
                  Descriptive Statistics 
                    
  Mean Standard Deviation Minimum         Maximum   Sig 
                    
  Trained Untrained Trained Untrained Trained Untrained Trained Untrained   
                    
Age (yrs)   24.40   22.80 ± 1.96 ± 1.87  21.00    20.00   27.0     25.00 0.078 
 
Height (m)     1.79     1.77 ± 0.05 ± 0.06   1.73  1.68     1.91    1.88 0.627 
 
Weight (kg)   79.43   88.86 ± 8.52 ± 9.93 71.66 77.57 101.15   104.30 0.035* 
 
BMI (kg·m-2)   24.83   28.24 ± 1.36 ± 2.68   23.40     23.80  27.70  32.60 0.002* 
 
Predicted VO2 
Max (mL·kg-1·min-1)  46.30  37.60 ± 1.59 ± 2.70  44.30  32.60  48.90  40.80 0.047* 
          *Statistically significant at the P≤0.05 level. 
 
Procedures 
A double-blind, placebo-controlled crossover experimental design was used in this study. Prior to 
beginning any testing, the subjects were required to abstain from any caffeine ingestion for 1 wk to 
allow for a full caffeine “washout.” The subjects were also required to refrain from performing any 
strenuous exercise for 48 hrs prior to any testing.  All testing was performed in the morning and at the 
same time for each individual’s sessions. 
 
After a minimum of 48 hrs to recover from the YMCA protocol, the subjects completed two cycle 
ergometer trials to exhaustion at 80% of their predicted workload max with 48 to 96 hrs between 
trials. Thirty minutes prior to each trial, the subjects would ingest either 5 mg·kg-1 of caffeine per body 
weight dissolved in artificially colored and artificially flavored water or a placebo. 
 
Statistical Analyses 
Time to exhaustion data were analyzed using a Two-Way analysis of variance in order to determine if 
significant differences were produced between the placebo and caffeine trials for each Group and 
also to determine if significant differences were seen in the average change when compared between 
Groups. Statistical significance was set at the P≤0.05 level. 
 
RESULTS 
 
The predicted VO2 max for the Trained Group (46.3 mL·kg-1·min-1) was significantly higher than the 
predicted VO2 max of the Untrained Group (37.6 mL·kg-1·min-1) (Table 2). This finding indicates that 
the two groups were significantly different in aerobic capacity. Mean time to exhaustion for the 
Trained Group was 786.4 ± 251.5 sec for the placebo trial and 810.7 ± 209.4 sec for the caffeine trial. 
This difference resulted in an average improvement of 3.1% in performance time (Table 3).   
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Table 3. The Trained Groups’ Results during the Placebo and Caffeine Trials. 
          Trained Group 
          
  Mean ± SD Min Max 
          
Placebo Trial (sec) 786.4 ± 251.5 470 1143 
 
Caffeine Trial (sec) 810.7 ± 209.4 465 1126 
     
      
 
For the Untrained Group, the mean time to exhaustion was 514.6 ± 107.8 sec for the placebo trial and 
567.3 ± 140.5 sec for the caffeine trial. This difference resulted in an improvement in performance of 
10.2% (Table 4). However, what is important is that, while both the Trained Group and the Untrained 
Group showed the appearance of an improvement in the caffeine trials compared to the placebo 
trials, neither was statistically significant (Trained Group, P=0.676 and Untrained Group, P=0.107). It 
was also determined that the improvements were not significant when compared between groups 
(P=0.225). When both groups were compared together, caffeine showed an insignificant mean 
increase of 38.5 sec versus the placebo (P=0.230). 
 
Table 4. The Untrained Groups’ Results during the Placebo and Caffeine Trials. 
Untrained Group 
          
  Mean ± SD Min Max 
          
Placebo Trial (sec)  514.6 ± 107.8 382 702 
 
Caffeine Trial (sec) 567.3 ± 140.5 375 736 
     
      
 
DISCUSSION 
 
It is well known that caffeine stimulates the central nervous system, which has a direct effect on the 
cardiovascular and muscular systems.  It is also understood that caffeine has a glycogen-sparing role 
during exercise by mobilizing the free-fatty-acid blood concentration as the primary fuel source for 
muscle contraction during endurance events. While there are other explanations for the role caffeine 
plays in sports, it was expected that the trained subjects would benefit from the use of caffeine more 
so than the untrained subjects. Moreover, it seemed reasonable that the untrained subjects would 
benefit to some degree from consuming a moderate dose of caffeine (5 mg·kg-1) as well.   
 
The major finding in this study is that there was no significant difference between the Trained Group 
and the Untrained Group. However, although it was not the purpose of this study to prove a particular 
point of view, it is likely that the results would have been different if the sample size in each Group 
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had been larger. What is important is that, while both the Trained Group and the Untrained Group 
showed the appearance of an improvement in the caffeine trials compared to the placebo trials, 
neither was statistically significant (Trained Group, P=0.676 and Untrained Group, P=0.107). It is also 
worth pointing out that the mean differences were not significant when compared between groups 
(P=0.225). Lastly, when both groups were compared together, caffeine showed a non-significant 
mean increase versus the placebo (P=0.230). 
 
Had the p-value for the different conditions tested in this study been 0.05, there would still have been 
a 5% chance that the subjects in both group experienced a caffeine stimulating effect on the 
cardiovascular and muscular systems just by chance. However, since the p-value for all comparisons 
was >0.05, the result is considered statistically non-significant and, therefore, it is justified in 
concluding that caffeine is not correlated with time to exhaustion in either the endurance trained 
subjects or the untrained subjects. This does not mean that caffeine did not help the subjects in both 
groups, but that it has not been proven to help. 
 
Although not significant, the Untrained Group did show a slightly higher improvement than the 
Trained Group (10.2% compared to 3.1%, respectively) from placebo to caffeine. This may have 
occurred for two reasons. First, the Untrained Groups’ placebo trial time to exhaustion was lower than 
the Trained Group, so there was more room for improvement in the caffeine trial. Second, since it is 
likely that the subjects in the Trained Group exercised more regularly than the subjects in the 
Untrained Group, it is assumed that they would better expect what a time trail to exhaustion would 
physically feel like. Although it is not considered ergogenic, one theory as to how caffeine provides a 
positive effect during aerobic exercise is the reduction in the subjects’ perceived pain. The Untrained 
Group may have felt the effect of the caffeine in the reduction of perceived exertion while the Trained 
Group may have reacted to the exertion that they expected to feel, which minimized the effect (Figure 
1).   
 
 
 
 
 
  
 
96 
In the present study, exhaustion occurred in ~12 min when the subjects in the Trained Group 
exercised at 80% of their predicted maximal exercise capacity while the untrained subjects exercised 
~8 min. Since it is likely that greater improvements are seen when subjects exercise for 20 min or 
more, the intensity of exercise may have been greater than 80% of predicted VO2 max. Also, while 
the 5 mg·kg-1 does has been shown to be effective in increasing high intensity exercise tolerance, it 
was ineffective when the bout of exercise was considerably shorter in duration (Figure 2).   
 
 
 
 
 
After a review of the literature, it would appear that longer duration exercise would help caffeine to 
produce a stronger ergogenic effect. For example, in this study, TTE with placebo was highest with 
the trained group at ~13 min but showed only a 3.1% improvement with caffeine.  Previous research 
indicates that the magnitude of improvement from caffeine ingestion increases with the duration of 
exercise trial. For instance, Bell and McLellan (2) studied two groups of subjects and found that doses 
of 5 mg·kg-1 of body weight of caffeine produced an improvement in performance of ~35%. Both of 
those groups originally averaged around 18 to 20 min for a cycle ergometer trial to exhaustion at 80% 
VO2 max. Since there is apparently a lack of research on the topic, observing the effects of caffeine 
as an ergogenic aid on cycle ergometer exercise to exhaustion on subjects whose TTE is considered 
shorter (10 to 20 min) should be a major focus of future studies.   
 
CONCLUSION 
 
The findings indicate that there was no ergogenic effect of caffeine on time to exhaustion in either 
endurance trained subjects or the untrained subjects. Because the Untrained Group failed to produce 
an improvement during the caffeine trials, continuation of the study of the ergogenic effects of 
caffeine on untrained men should be considered. Lastly, future investigations should consider the 
effects of caffeine as function of exercise time in both trained and untrained subjects.  
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